Bill Text: NY S05880 | 2011-2012 | General Assembly | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Designates tramadol as a schedule III narcotic drug, and eliminates hydrocodone from the list of schedule III narcotic drugs; provides that such compounds shall continue to be handled by licensed distributors in the manner applicable to schedule III controlled substances.

Spectrum: Moderate Partisan Bill (Republican 11-2)

Status: (Engrossed - Dead) 2012-02-13 - referred to health [S05880 Detail]

Download: New_York-2011-S05880-Introduced.html
                           S T A T E   O F   N E W   Y O R K
       ________________________________________________________________________
                                         5880
                              2011-2012 Regular Sessions
                                   I N  S E N A T E
                                   September 9, 2011
                                      ___________
       Introduced  by Sens. HANNON, MARCELLINO, KLEIN -- read twice and ordered
         printed, and when printed to be committed to the Committee on Rules
       AN ACT to amend the public health law, in relation to designating trama-
         dol as a schedule III narcotic drug; and to repeal paragraphs 3 and  4
         of  subdivision (e) of schedule III of section 3306 of such law relat-
         ing to the designation of hydrocodone as a schedule III narcotic drug
         THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
       BLY, DO ENACT AS FOLLOWS:
    1    Section  1.  Paragraphs  3 and 4 of subdivision (e) of schedule III of
    2  section 3306 of the public health law are REPEALED and a  new  paragraph
    3  10 is added to read as follows:
    4    (10) TRAMADOL IN ANY QUANTITIES.
    5    S 2. This act shall take effect immediately.
        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                             [ ] is old law to be omitted.
                                                                  LBD13421-02-1
feedback